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Abstract
Background: Despite evidence that up to 35% of patients with cancer experience significant distress, access to
effective psychosocial care is limited by lack of systematic approaches to assessment, a paucity of psychosocial
services, and patient reluctance to accept treatment either because of perceived stigma or difficulties with access
to specialist psycho-oncology services due to isolation or disease burden. This paper presents an overview of a
randomised study to evaluate the effectiveness of a brief tailored psychosocial Intervention delivered by health
professionals in cancer care who undergo focused training and participate in clinical supervision.
Methods/design: Health professionals from the disciplines of nursing, occupational therapy, speech pathology,
dietetics, physiotherapy or radiation therapy will participate in training to deliver the psychosocial Intervention
focusing on core concepts of supportive-expressive, cognitive and dignity-conserving care. Health professional
training will consist of completion of a self-directed manual and participation in a skills development session.
Participating health professionals will be supported through structured clinical supervision whilst delivering the
Intervention. In the stepped wedge design each of the 5 participating clinical sites will be allocated in random
order from Control condition to Training then delivery of the Intervention. A total of 600 patients will be recruited
across all sites. Based on level of distress or risk factors eligible patients will receive up to 4 sessions, each of up to
30 minutes in length, delivered face-to-face or by telephone. Participants will be assessed at baseline and 10-week
follow-up. Patient outcome measures include anxiety and depression, quality of life, unmet psychological and
supportive care needs. Health professional measures include psychological morbidity, stress and burnout. Process
evaluation will be conducted to assess perceptions of participation in the study and the factors that may promote
translation of learning into practice.
Discussion: This study will provide important information about the effectiveness of a brief tailored psychological
Intervention for patients with cancer and the potential to prevent development of significant distress in patients
considered at risk. It will yield data about the feasibility of this model of care in routine clinical practice and
identify enablers and barriers to its systematic implementation in cancer settings.
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Background
The mental health burden of cancer
Approximately 35% of patients with cancer experience
clinically significant distress, patients with poorer prog-
nosis and those with higher levels of disease burden being
especially at risk [1]. The International Psycho-Oncology
Society (IPOS) is the international multidisciplinary body
which advocates for attention to psychological, social
and behavioural issues in cancer care. In 2010 IPOS
proposed a new international quality standard, endor-
sing Distress as the “Sixth Vital Sign” in order to raise
awareness of the need to evaluate and monitor distress
as part of routine cancer care. However strategies to
embed such evaluation and subsequent interventions
into routine care have received less attention. In Aus-
tralia Clinical Practice Guidelines for the Psychosocial
Care of Adults with Cancer (PCPG) describe the bene-
fits of psychosocial Interventions in this population to
promote well-being [2], and there is emerging evidence
that psychosocial Interventions may prevent the devel-
opment of frank disorder such as Major Depression
[3]. Despite this evidence, rates of referral for specialist
treatment are low - in one Australian study 75% of
patients with clinically significant anxiety or depression
did not receive any counselling or psychological treat-
ment [4]. Low referral rates may reflect limited clini-
cian ability to detect distress, exemplified by research
in which oncologists identified only 17% of clinically
anxious and 6% of clinically depressed patients [5].
This limited detection may relate to patient reluctance
to volunteer emotional concerns because of the belief
that distress is inevitable, or that nothing can be done
to assist [6] meaning that health professionals must
often rely on non-verbal cues to identify distress, a dif-
ficult task in the absence of specific training [7].
Stigma about mental illness may be another reason
that patients are reluctant to disclose emotional con-
cerns or accept referral if this is offered [8,9].
Limited access to suitably qualified professionals to
provide psychosocial care may undermine clinician
enthusiasm about detecting distress - why identify a
problem if it cannot be addressed? But even in settings
with access to specialist staff, psychosocial care is not
uniformly offered. For example a cross-sectional survey
found that psychosocial advice was provided for up to
50% of patients at diagnosis, but at completion of treat-
ment patients were seldom given advice about adjust-
ment to survivorship [10], despite the fact that the
transition from active treatment to follow-up is a time
of increased psychological vulnerability [2].
In addition to the obvious workforce barriers to provi-
sion of optimal psychosocial care, broader systems issues
are likely to play a role. In clinical services under severe
pressure to provide patient care despite limited
resources, psychosocial care may be assigned a lower
priority than biomedical care. In these settings, absence
of defined pathways to routinely assess and address psy-
chosocial need means that these issues “slip under the
radar”, with the consequence that patient need is unmet.
Depression and anxiety have a profound adverse impact
on well-being of patients with medical illness [11] and
thus merit treatment in their own right. However at a
systems level, it is vital to recognise that depression and
anxiety are associated with reduced capacity to cope
with disease burden, more frequent presentations to
health services and increased costs [12], putting further
strain on a struggling health system.
Addressing barriers to care - implementation of
systematic flexible approaches embedded in clinical care
Given the limitations of health professionals’ identifica-
tion of patient distress, implementation of systematic
evidence-based approaches to screening and detection
of distress is essential to ensure that patients’ needs are
appropriately identified [13]. Instruments such as the
Distress Thermometer which has an accompanying pro-
blem list provide a starting point for assessment of each
patient’s unique needs [14]. Patient need may also relate
to vulnerability, identified by the presence of risk fac-
tors, even in the absence of current distress. The Aus-
tralian National Breast and Ovarian Cancer Centre
(NBOCC) has developed a structured template to pro-
mote a systematic approach to risk assessment [15],
based on evidence derived from the Clinical Practice
Guidelines for the Psychosocial Care of Adults with
Cancer [2]. However to date there has been no research
examining psychosocial Interventions in this vulnerable
population, in particular whether provision of informa-
tion and self-management strategies might prevent the
development of disorder such as depression.
Having identified patient distress, a critical next step is
to determine the severity and sources of distress. Inter-
national research highlights the need to move beyond
generic ("one size fits all”) approaches to an individua-
lised approach, for example addressing issues such as
dignity and personal integrity [16]. This is consistent
with a tiered model of care in which psychosocial inter-
ventions are tailored to the individual’s level of need
[17] - only the most distressed patients are offered spe-
cialist referral - the needs of patients with mild distress
being addressed through more basic supportive inter-
ventions, often delivered by non-specialist health profes-
sionals. Our research has demonstrated that focused
training leads to improved knowledge, confidence and
skills of oncology nurses [18,19] meaning that nurses
could potentially deliver psychosocial care for less
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severely distressed patients. A UK study supports the
feasibility of this model of care, demonstrating that
oncology nurses without prior training in psychosocial
interventions can be trained to deliver a brief Interven-
tion for depressed cancer patients, leading to improve-
ment in symptoms of depression [20]. In addition to the
obvious implications in terms of improving patient
access to care, such an approach is likely to counter
stigma as support provided by breast care nurses is
regarded by patients as both effective and highly accep-
table [21]. A further advantage of an approach which is
embedded in routine clinical care is that patients who
have high disease morbidity may find this support more
accessible and timely.
Another strategy to enhance acceptability to patients
and improve sustainability is to adopt more flexible
approaches to the delivery and style of interventions.
For example telephone-based counselling is likely to be
highly acceptable to patients from rural areas or those
with disease burden which limits travel. Randomised
trials of telephone-based interventions have been
successful in improving patient pain and depression
[22] and distress [23]. Adaptation of traditional time-
intensive psychosocial therapies into brief, more flexible
formats is likely to improve acceptability, and also
increases the feasibility of these interventions being
incorporated into routine clinical care. This approach is
supported by evidence: simple behavioural therapies
appear to be as effective as more complex cognitive
techniques [24], and a component analysis of therapy
for treatment of depression concluded that simple beha-
vioural activation was as effective as more complex
treatments [25]. Minimal-contact psychotherapy has also
been demonstrated to be effective for depressed patients
in primary care [26], and brief targeted therapy for
medically-ill patients experiencing demoralisation has
been described [27].
Methods/Design
Study aims and hypotheses
The study’s primary aim is to evaluate the effectiveness
of a brief psychosocial Intervention in reducing depres-
sion and anxiety in patients with cancer who are dis-
tressed, but not severely depressed, or who are at risk of
becoming depressed. The Intervention will be delivered
by health professionals who have participated in focused
training and who receive clinical supervision during
delivery of the Intervention. Additional aims are to
examine the impact of the psychosocial Intervention on
patient unmet needs, quality of life, and scores of
demoralisation.
Secondary aims are to examine any impact on stress
and burnout and psychological adjustment of the health
professionals who deliver the psychosocial Intervention,
to assess the feasibility of integration of the Intervention
into clinical practice, and to identify health professional,
systems and patient barriers to the implementation of
this model of systematic tailored psychosocial Interven-
tions in clinical care.
It is hypothesised that:
1. Patients receiving the Intervention will demonstrate
greater improvement in depression/anxiety scores and
reduction in depression/anxiety “caseness” compared
with patients receiving Usual Care.
2. The Intervention will be associated with lower rates
of depression/anxiety and increasing reduction in
depression/anxiety scores over time in patients of the
cancer services.
3. There will be no changes in health professional
stress and burnout.
Intervention
This study comprises two discrete components:
a) Training of health professionals who will deliver the
psychosocial Intervention
b) Delivery of the psychosocial Intervention by the
trained health professionals.
The design for this randomised study is a stepped-
wedge cluster design, a type of crossover design in
which different clusters (the clinical sites) cross over in
one direction only, from Control to Training then Inter-
vention [28]. At the conclusion of the study, all sites
will have received Training and be providing the Inter-
vention [29] delivered by health professionals who have
received training at that site as depicted in Table 1.
The nature of the Intervention will be tailored to the
level of need of the patient, eligible patients receiving a
“low-intensity” or “medium-intensity” Intervention, allo-
cated according to the Algorithm depicted in Table 2.
i) Low-intensity Intervention
Patients who have a Hospital Anxiety and Depression
Scale (HADS) [30] score of less than 8, in addition to
either the presence of risk factors or current distress
(DT score 4 or greater) will receive the low-intensity
Intervention. This consists of a suite of consumer
resources demonstrated to be effective and acceptable,
including the consumer version of the Clinical Practice
Guidelines for the Psychosocial Care of Adults with
Cancer: Cancer, how are you travelling? [31]. The
resource suite will include practical information about
support groups and describe structured problem-solving
and simple cognitive strategies, which can be employed
to deal with concerns. Engagement of patients through
educational and other resources has been demonstrated
to be effective in collaborative care models [32] with the
potential for patients to develop self-care and other stra-
tegies sustained beyond the duration of the Intervention.
Engagement of patients in self-care strategies is strongly
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endorsed by consumer advisors to this study. In addition
it has inherent appeal in terms of cost and potential to
be delivered in diverse settings.
ii) Medium-intensity Intervention
Patients who have a HADS score of 8-21 inclusive will
receive the medium-intensity Intervention, irrespective
of the presence or absence of risk factors Simple provi-
sion of information alone has been demonstrated to be
insufficient to treat depressed patients [33], meaning
that a more intensive Intervention is required for
depressed patients [34]. The medium-intensity Interven-
tion consists of up to 4 tailored sessions, delivered by a
health professional who has participated in specific
training in order to be skilled to deliver the Interven-
tion. These sessions will be conducted face-to-face or by
telephone, depending on mutual convenience of patient
and the health professional. All medium-intensity Inter-
vention sessions will be up to 30 minutes in duration,
conducted over a 4-week period. The duration of this
Intervention reflects clinical practice with brief therapy,
and represents a feasible time commitment for the
health professional.
All medium-intensity Intervention sessions will have
the following core principles:
• Focus on engagement with the patient
• Eliciting and exploring key patient concerns
• Establishment of an agreed treatment plan with the
patient, focusing on strategies to address Distress. This
treatment plan will be developed in consultation with
the patient after review of their self-report on the Dis-
tress Thermometer as above. The treatment plan will
incorporate detailed assessment and referral for further
assistance as necessary, for example with practical con-
cerns, financial issues, or physical symptoms such as
pain or nausea. The need for referral will depend on the
background training of the health professional delivering
the Intervention - for example, a nurse will often be
able to assess and initiate symptom management whilst
a radiation therapist would refer the patient to a doctor
or nurse.
• Regular review of this plan and its progress through
the process of Clinical Case Review (clinical
supervision).
The medium-intensity Intervention has been designed
to ensure flexibility to select the most appropriate stra-
tegies to assist each patient, based on the patient’s self-
reported areas of concern as identified on the Distress
Thermometer. During their training health professionals
will acquire the necessary skills to critically analyse the
nature of the patient’s concerns and devise a tailored
Intervention specific to the patient’s needs. Examples of
specific techniques which may be used by the health
professional in the medium-intensity Intervention
depending on patient need are provided in Table 3.
All health professionals delivering the medium-intensity
Intervention will participate in Clinical Case Review
Table 1 Stepped wedge design
Epoch 1 Epoch 2 Epoch 3 Epoch 4 Epoch 5 Epoch 6 Epoch 7
Site 1 Control TRAINING Intervention Intervention Intervention Intervention Intervention
Site 2 Control Control TRAINING Intervention Intervention Intervention Intervention
Site 3 Control Control Control TRAINING Intervention Intervention Intervention
Site 4 Control Control Control Control TRAINING Intervention Intervention
Site 5 Control Control Control Control Control TRAINING Intervention
Week 1 10 20 30 40 50 60
The Intervention is sequentially rolled-out across sites in random order over a number of time periods (Epochs).
Table 2 Algorithm for patient allocation to Intervention
DT1 score <4 DT1 score 4 or greater
No risk factors + risk factors2
HADS3 < 8
+/- risk factors2
HADS3 < 8
+/- risk factors2
HADS3 8-21
+/- risk factors2
HADS3 22 or greater
Usual care Low-intensity Intervention
Patient self-directed
resource suite only
Medium-
intensity
Intervention
Tailored
psychosocial
Intervention
delivered by
trained Health
Professional
Specialised
Treatment
with an
appropriately
qualified
practitioner
via a pre-defined
clinical pathway
DT1: Distress Thermometer.
Risk Factors2: Risk factors as identified in the National Breast and Ovarian Cancer Centre Psychosocial Checklist (PSCL).
HADS3: Hospital Anxiety and Depression Scale.
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(clinical supervision) facilitated by an experienced con-
sultation-liaison psychiatrist. Sessions will be conducted
in group format on a weekly basis. Health professionals
will use these sessions to discuss the patients for whom
they have delivered the medium-intensity Intervention,
including discussion of specific components of the Inter-
vention, difficulties encountered by the health profes-
sional, and be assisted to devise strategies to respond.
A pre-determined structure will be followed to ensure
consistency of Clinical Case Review across sites.
The health professional will record details of each ses-
sion in a structured logbook noting precise details of all
Intervention contacts with each patient including date,
duration, mode (face-to-face or telephone), themes dis-
cussed and referrals such as to physiotherapy, or medi-
cal review of pain.
iii) High-intensity Intervention
Patients who have high levels of distress as measured on
the HADS (scores of 22 or greater) have needs beyond
the training of the health professionals participating in
this study and require a high-intensity Intervention. All
patients in this category will be referred for Specialised
Treatment (high-intensity Intervention) with an appro-
priately qualified practitioner via a pre-defined clinical
pathway at the respective site.
iv) Usual Care
Patients with no current distress (DT Score < 4) and no
risk factors (on Psychosocial Checklist) will not receive
any additional information or psychosocial support
related to coping with cancer beyond the normal clinical
practice at the site where they are receiving cancer care.
They will continue to participate in follow-up or cancer-
specific treatment as usual. They will not have contact
with the trained health professionals at that site other
than in the usual course of clinical care.
Participants
Health professionals
Health professionals from the disciplines of nursing,
occupational therapy, speech pathology, nutrition and
dietetics, physiotherapy or radiation therapy will be eli-
gible to participate in training if they: (1) have at least
12 months’ clinical experience in oncology (2) are cur-
rently engaged in patient contact (minimum of 6 hours
per week) (3) have a commitment to undertake the
necessary training and (4) are working in a setting in
which they can deliver the Intervention. Health profes-
sionals who meet the selection criteria will be offered
entry into the study by the Investigators and will com-
plete baseline measures before receiving a self-directed
training manual and participating in a day-long skills
development session. The core elements of the training
will be (1) Supportive/expressive - encouraging expres-
sion of emotions; validating the individual’s experiences;
empathic listening, and provision of information (2) Cog-
nitive-behavioural - teaching skills in problem-solving;
identifying and challenging automatic thoughts; refram-
ing; relaxation training and guided imagery (3) Dignity-
conserving - encouraging reflection on themes of coher-
ence, isolation, hope, helplessness, purpose and courage,
as well as practical needs. This training will be com-
pleted over a period of 10 weeks. Psychologists, social
workers and psychiatrists will not be eligible to partici-
pate as (1) it is considered that their core skills encom-
pass the material included in the training, and
(2) patients may be referred to these professionals as
part of the intervention, for example a patient may be
referred to a social worker because of financial concerns
(as per Table 3). The number of health professionals to
be trained at each site will vary depending on when that
site is randomised. We aim to train sufficient numbers
of health professionals so that no health professional is
required to deliver the Intervention to more than 2
patients per Epoch (10-week cycle depicted in Table 1).
Patients
Inclusion criteria are: (1) aged 18 years or over (2) conse-
cutive patients attending outpatient oncology clinics at
each site (3) currently receiving active treatment for can-
cer OR have completed active treatment within the pre-
vious 2 months OR have been diagnosed with recurrent/
Table 3 Examples of strategies to address patient distress
Type of Distress Specific techniques to address Distress
Practical - finances; difficulty with
domestic tasks
Referral to Social Work; clarification of concerns; structured problem-solving; challenging black and white
thinking about the need to perform domestic tasks; re-assigning priorities.
Family - concerns about children Listening; acknowledgment of concerns; explanation about children’s needs; discussion about the
benefits of maintaining routine; reassuring children that they have not caused the cancer.
Emotional - anxiety about
chemotherapy
Explanation; identification of automatic thoughts; challenging negative cognitions; relaxation and guided
imagery.
Physical - pain Referral for medical review; exploration of concerns about pain; identifying and challenging misbeliefs e.g.
about becoming dependent on analgesia or that use of morphine implies inevitably poor prognosis;
relaxation and guided imagery.
Spiritual - shame about dependence,
low sense of worth
Dignity-conserving techniques e.g. exploration of past experiences, reflection on strengths; engaging in
creative discussion about ways to feel in control; framing assistance as necessary to maintain dignity.
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advanced cancer within the previous 2 months. Exclusion
criteria are: (1) inability to speak and read English, (2)
receiving current specialised psychological treatment
from a psychologist, psychiatrist, or other trained coun-
sellor, (3) currently taking antidepressant medication, (4)
health status precludes ability to complete questionnaires
and participate in up to four psychosocial Intervention
sessions and follow-up at 10 weeks, and (5) recruited in
any previous Epoch of this study (that is, patients can
only participate during one Epoch).
We will recruit 20 patients per site per Epoch (with the
exception of the Training Epochs during which no
patients will be recruited) with a total sample size of 600
patients. No patient who has been recruited in a previous
Epoch will be eligible to participate in subsequent
Epochs. Primary outcome measure is change in HADS
score over ten weeks from enrolment to follow-up. Esti-
mates of HADS in similar populations [35] are a mean of
17.8 with SD = 9.0, with a 10%-15% difference in mean
change-scores assumed to be clinically significant. To
detect this difference, with power = 80%, in a before-after
design assuming a correlation 0.5 within patient over
time, about 200 patients in each group are needed (Stata
IC, version 10). Patients will be clustered by clinic, but
we have no data on which to estimate intraclass correla-
tion for the HADS scores; so will assume a design effect
of deff = 1.5 to accommodate clustering, and hence we
will require 600 patients in all; across five clinics, so we
will seek to enrol 120 patients per site.
Study Integrity
Ethical approval for this study has been obtained from
the Human Research Ethics Committees of Royal Bris-
bane and Women’s Hospital and the University of
Queensland. The study design will be guided by the
CONSORT statement [36]. Each site will be randomly
allocated to the Training phase which will be immedi-
ately followed by Intervention phase, by the study statis-
tician. Every consecutive patient attending the
outpatient oncology department at each site will be
screened for eligibility and enrolled if eligible and con-
senting. Careful documentation of outpatient atten-
dance, subsequent enrolments and consent interviews
will ensure that no patient is “selected” for inclusion or
exclusion from the study. No patients will be rando-
mised, and whether or not they receive the Intervention
will be based on the algorithm depicted in Table 2. It is
not possible to blind patients to the Intervention. No
health professionals will be randomised. All participating
health professionals will receive the training and deliver
the psychosocial Intervention to eligible patients. It is
not possible to blind health professionals delivering the
psychosocial Intervention to the treatment status of
patients.
Measures
Health Professional assessment instruments
Demographic details, including professional background
and training will be obtained at intake. The following
measures will be completed at baseline and on comple-
tion of the study when the health professional has com-
pleted delivery of the psychosocial Intervention.
Psychological distress The General Health Question-
naire 28 (GHQ) [37] will be used to assess general dis-
tress. This is a brief self-report measure which has been
extensively used to screen for psychosocial morbidity,
with good reliability and validity.
Stress and burnout Occupational stress and burnout
will be assessed with the Maslach Burnout Inventory
(MBI) [38], a widely-used measure of occupational stress
and burnout which assesses Emotional Exhaustion,
Depersonalisation and Personal Accomplishment
Perceptions of participants Semi-structured interviews
will be conducted with a subset of five health profes-
sionals from each site to examine their perceptions of
the Training and delivery of the Intervention, including
practical aspects of delivery and impediments to the
Intervention, as well as reflections about their experi-
ence of Clinical Case Review and perceived impact of
participation in the study on their clinical practice.
Patient assessment instruments
Demographic details, disease stage and current treat-
ment status will be obtained at intake. The following
measures will be completed at baseline and 10-week fol-
low-up.
Distress The Distress Thermometer will be used to
assess distress. The Distress Thermometer is a self-rated
instrument in which patients indicate their Distress (0 =
No distress; 10 = Extreme distress), nominating the
source of Distress: Practical; Physical; Family; and Emo-
tional or Spiritual/Religious [14]. A cut-off score of 4
has the greatest sensitivity and specificity compared with
other validated measures [39].
Psychosocial Risk Factors The Psychosocial Checklist is
a structured template based on evidence in the Clinical
Practice Guidelines for the Psychosocial Care of Adults
with Cancer about known risk factors for development
of depression and anxiety in cancer patients [15]. It has
been successfully implemented in multiple clinical ser-
vices across Australia.
Mood The Hospital Anxiety and Depression Scale
(HADS) [30] will be used to assess mood. This 14-item
scale has good reliability and validity and has been
extensively used in studies of cancer patients, cut-off
scores of 22 and above representing severe disorder, and
less than 8 representing no disorder.
Unmet Psychological Supportive Care Needs The Sup-
portive Care Needs Survey-Short-Form SCNS-SF 34
[40] will assess patients’ needs for help over the last
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month across the following domains: Psychological;
Health Systems and Information; Patient Care and Sup-
port, and Physical and Daily Living needs.
Quality of life FACT-G (Functional Assessment of
Cancer Scale - General) [41] is a widely-used measure
of quality of life in the cancer population, with well-
being subscales: Physical; Social/family; Emotional, and
Functional.
EQ-5 D (EuroQoL) [42] is a brief self-report measure
of quality of life from which a QALY can be calculated.
This measure has been used in intervention studies with
depressed patients [43].
Experience of demoralisation DS (Demoralisation
Scale) is a 24 item self-report scale with a Cronbach
alpha of .96, measuring depression commonly seen in
the physically ill [44]. Norms have been established in a
non-clinical sample [45].
Health service use Patients will maintain a record of
visits to General Practitioners and any contact with
community or hospital-based support services, using a
structured template.
Statistical analyes
Quantitative analysis
We will compute and compare the average change in
HADS scores among patients enrolling during Interven-
tion Epochs with scores of patients enrolling during
Control Epochs. The strength of the stepped-wedge
design is that we will be able to account for systematic
differences between sites and times during the trial, and
also for case-mix differences between patients.
We will use a patient-level hierarchical analysis model
to accommodate these potentially confounding factors.
With this model, we can adjust for case-mix differences
between sites, as well as allow for specific site character-
istics (other than presence/absence of the Intervention).
A generalised estimating equation (GEE) linear or logis-
tic model will be implemented [28] to estimate the
effect of the Intervention on the patients’ change in
HADS scores and the prevalence of depression “case-
ness” at each site. Stata Version 10 (StataCorp, 2008)
will be used for all statistical analyses.
Qualitative analysis
Semi-structured interviews with health professionals will
be tape-recorded, transcribed verbatim and analysed to
determine similarity of themes or differences between
barriers to delivery of supportive care previously identi-
fied [46]. Clinical Case Review sessions will be recorded,
transcribed and similarly analysed.
A random selection of 10% of all HP log books will be
examined to determine adherence to the training and
identify patterns of referral (for example because of
pain) and delineate professional, patient or system bar-
riers to delivery of the Intervention.
Discussion
This study will examine the effectiveness and feasibility
of a model of psychosocial care in which patients are
systematically screened for psychosocial needs and risk
and then assigned to receive therapy tailored to their
precise level of need. Use of novel and readily accessible
service providers to deliver the Intervention after partici-
pation in focused training is an innovative approach
designed to improve patient access to timely psychoso-
cial care, and represents an efficient approach in the
face of limited access to scarce psychosocial resources.
Inclusion of patients who are considered at risk of anxi-
ety and depression even if not currently distressed is an
important strategy to examine the potential to prevent
the development of more serious distress. The brief flex-
ible mode of delivery as part of cancer clinicians’ routine
practice is aimed to address the stigma of psychosocial
care and facilitate uptake by patients whose physical
condition would make attendance for longer therapies
difficult. Incorporation of clinical supervision is a central
platform to assist health professionals delivering the
Intervention, ensure quality of care, monitor patient
responses and reduce the potential for development of
health professional stress. The incorporation of in-depth
interviews with health professional participants and
detailed analysis of the process of clinical supervision
will provide fine-grained insights into enablers and bar-
riers of this model of care and guide refinement before
its more widespread implementation. Recognition of
emotional distress as a vital clinical sign in cancer care
has been a major achievement in cancer care policy.
One of the barriers to achieving the intended goals of
such policy in psychosocial care is the effective transla-
tion of the substantial body of evidence regarding
screening and psychosocial treatments into routine clini-
cal practice by a range of cancer clinicians in a range of
settings. This study aims to help address this gap in
knowledge, by training health professionals who work
closely with cancer patients in daily practice. More
importantly an innovative component of this study is
the support and mentoring of health professionals pro-
viding psychosocial care as a strategy to bridge knowl-
edge and practice change, while using mixed
methodology to study the processes of such clinical
practice change.
Acknowledgements
This study is funded by beyondblue: the national depression initiative.
Author details
1School of Medicine, University of Queensland and Royal Brisbane and
Women’s Hospital, Brisbane, Australia. 2University of Newcastle and John
Hunter Hospital, Newcastle, Australia. 3Monash Medical Centre, Melbourne,
Australia. 4Queensland University of Technology, Brisbane, Australia.
5University of Melbourne and Peter MacCallum Cancer Centre, Melbourne,
Turner et al. BMC Cancer 2011, 11:48
http://www.biomedcentral.com/1471-2407/11/48
Page 7 of 9
Australia. 6School of Public Health and Preventive Medicine, Monash
University, Melbourne, Australia. 7Cancer Council Queensland, Brisbane,
Australia. 8Haematology and Oncology Clinics of Australasia, Brisbane,
Australia. 9Melanoma Patients Australia, Brisbane, Australia.
Authors’ contributions
JT, BK and DC developed the study concept, aims and initiated the project.
PY, SA, DJ, SC, MH and LMcF assisted further in the refinement of the
concept and development of the protocol. JT, BK, DC, SA and MH will
implement the protocol and oversee collection of data. JT, BK and DC will
provide health professional training and clinical supervision, in consultation
with other authors. JT was responsible for the drafting of the manuscript. All
authors have read and approved the final manuscript.
Competing interests
DC is a member of the Research Advisory Group of beyondblue, the National
Depression Initiative. He absented himself from reviews of grant applications
and was not involved in discussion of any funding decisions.
Received: 22 November 2010 Accepted: 1 February 2011
Published: 1 February 2011
References
1. Zabora J, Brintzenmhofeszoc K, Curbow B, Hooker C, Piantadosi S: The
prevalence of psychological distress by cancer site. Psycho-Oncology
2001, 10:19-28.
2. National Breast Cancer Centre and National Cancer Control Initiative:
Clinical practice guidelines for the psychosocial care of adults with
cancer. National Breast Cancer Centre Camperdown, NSW; 2003.
3. Kissane DW, Grabsch B, Clarke DM, Smith GC, Love AW, Bloch S, Snyder RD,
Li Y: Supportive-expressive group therapy for women with metastatic
breast cancer: survival and psychosocial outcome from a randomized
controlled trial. Psycho-Oncology 2007, 16:277-286.
4. Pascoe S, Edelman S, Kidman A: Prevalence of psychological distress and
use of support services by cancer patients at Sydney hospitals. Australian
and New Zealand Journal of Psychiatry 2000, 34:785-791.
5. Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A: How well do medical
oncologists’ perceptions reflect their patients’ reported physical and
psychosocial problems? Cancer 1998, 83:1640-1651.
6. Maguire P: Improving communication with cancer patients. European
Journal of Cancer 1999, 35:2058-2065.
7. Butow PN, Brown RF, Cogar S, Tattersall MHN: Oncologists’ reactions to
cancer patients’ verbal cues. Psycho-Oncology 2002, 11:47-58.
8. Barney LJ, Griffiths KM, Christensen H, Jorm AF: Exploring the nature of
stigmatising beliefs about depression and help-seeking: Implications for
reducing stigma. BMC Central. Public Health 2009, 9:61-71.
9. Schomerus G, Matschinger H, Angermeyer MC: The stigma of psychiatric
treatment and help-seeking intentions for depression. European Archives
of Psychiatry and Clinical Neuroscience 2009, 259:298-306.
10. Steginga SK, Campbell A, Ferguson M, Beeden A, Walls M, Cairns W,
Dunn J: Socio-demographic, psychosocial and attitudinal predictors of
help seeking after cancer diagnosis. Psycho-Oncology 2008, 17:997-1005.
11. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustan B: Depression,
chronic diseases, and decrements in health: results from the World
Health Surveys. The Lancet 2007, 370:851-858.
12. Katon W, Lin E, Kroenke K: The association of depression and anxiety with
medical symptom burden in patients with chronic medical illness.
General Hospital Psychiatry 2007, 29:147-155.
13. Mitchell AJ, Hussain N, Grainger L, Symonds P: Identification of patient-
reported distress by clinical nurse specialists in routine oncology
practice: a multicenter study. Psycho-Oncology 2010 [http://onlinelibrary.
wiley.com/doi/10.1002/pon.1815/pdf].
14. NCCN Distress Management. V.I.2008. NCCN. 2007.
15. Psychosocial Checklist. 2008 [http://www.nbocc.org.au/health-
professionals/clinical-best-practice/psychosocial-tools-a-proformas], (accessed
22.4.10) NBOCC, Camperdown, NSW.
16. Chochinov HM: Dignity-conserving care - A new model for palliative
care. Journal of the American Medical Association 2002, 287:2253-2260.
17. Hutchison SD, Steginga SK, Dunn J: The tiered model of psychosocial
Intervention in cancer: a community-based approach. Psycho-Oncology
2006, 15:541-546.
18. Steginga S, Dunn J, Dewar A, McCarthy A, Yates P, Beadle G: Impact of an
Intensive Nursing Education Course on Nurses’ Knowledge, Confidence,
Attitudes, and Perceived Skills in the Care of Patients with Cancer.
Oncology Nursing Forum 2005, 32:375-381.
19. Turner J, Clavarino A, Butow P, Yates P, Hargraves M, Connors V,
Hausmann S: Enhancing the capacity of oncology nurses to provide
supportive care for parents with advanced cancer: evaluation of an
educational intervention. European Journal of Cancer 2009, 45:1798-1806.
20. Strong V, Waters R, Hibberd C, Murray G, Wall L, Walker J, McHugh G,
Walker A, Sharpe M: Management of depression for people with cancer
(SMaRT oncology 1): a randomized trial. The Lancet 2008, 372:40-48.
21. McArdle JMC, George WD, McArdle CS, Smith DC, Moodie AR, Hughson AV,
Murray GD: Psychological support for patients undergoing breast cancer
surgery: a randomised study. British Medical Journal 1996, 312:813-816.
22. Kroenke K, Theobald D, Wu J, Norton K, Morrison G, Carpenter J, Tu W:
Effect of telecare management on pain and depression in patients with
cancer. A randomised trial. Journal of the American Medical Association
2010, 304:163-171.
23. Marcus AC, Garrett KM, Cella D, Wenzel L, Brady MJ, Fairclough D, Pate-Willig M,
Barnes D, Embso SP, Kluhsman LC, Sedlacek S, Flynn PJ: Can telephone
counselling post-treatment improve psychosocial outcomes among early
stage breast cancer survivors? Psycho-Oncology 2010, 19:923-932.
24. Lovell K, Richards D: Multiple access points and levels of entry (MAPLE):
ensuring choice, accessibility and equity for CBT services. Behavioural
and Cognitive Psychotherapy 2000, 28:379-391.
25. Jacobson NS, Dobson KS, Traux PA, Addis ME, Koerner K, Gollan JK,
Gortner E, Prince SE: A component analysis of cognitive-behavioural
treatment for depression. Journal of Consulting and Clinical Psychology
1996, 64:295-304.
26. Willemse GR, Smit F, Cuijpers P, Tiemens BG: Minimal-contact
psychotherapy for sub-threshold depression in primary care. British
Journal of Psychiatry 2004, 185:416-421.
27. Griffith JL, Gaby L: Brief psychotherapy at the bedside: Countering
demoralisation from medical illness. Psychosomatics 2005, 46:109-116.
28. Hussey MA, Hughes JP: Design and analysis of stepped wedge cluster
randomised trials. Contemporary Clinical Trials 2007, 28:182-191.
29. Brown CA, Lilford RJ: The stepped wedge trial design: a systematic
review. BMC Medical Research Methodology 2006, 6:54-60.
30. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta
Psychiatr Scand 1983, 67:362-370.
31. Cancer: how are you travelling? 2007 [http://www.nbocc.org.au/view-
document-details/pcac-cancer-how-are-you-travelling], (accessed 22.4.10)
NBOCC, Camperdown. NSW.
32. Katon W, Von Korff M, Lin E, Simon G, Walker E, Bush T, Ludman E:
Collaborative management to achieve treatment guidelines: Impact on
depression in primary care. Journal of the American Medical Association
1995, 273:1026-1031.
33. Marks IM, Mataix-Cols D, Kenwright M, Cameron R, Hirsch S, Gega L:
Pragmatic evaluation of computer-aided self-help for anxiety and
depression. British Journal of Psychiatry 2003, 183:57-63.
34. Christensen H, Griffiths KM, Mackinnon AJ, Brittliffe K: Online randomized
controlled trial of brief and full cognitive behaviour therapy for
depression. Psychological Medicine 2006, 36:1737-1746.
35. Cameron IM, Crawford JR, Lawton K, Reid IC: Psychometric comparison of
PHQ-9 and HADS for measuring depression severity in primary care.
British Journal of General Practice 2008, 58:32-36.
36. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbounre D,
Gotzscge PC, Lang T, for the CONSORT Group: The revised CONSORT
statement for reporting randomized trials: Explanation and elaboration.
Annals of Internal Medicine 2001, 134:663-694.
37. Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, Rutter C:
The validity of two versions of the GHQ in the WHO study of mental
illness in general health care. Psychological Medicine 1997, 27:191-197.
38. Maslach C, Jackson SE: The measurement of experienced burnout. Journal
of Occupational Behaviour 1981, 2:99-113.
39. Ransom P, Jacobsen PB, Booth-Jones M: Validation of the distress
thermometer with bone marrow transplant patients. Psycho-Oncology
2006, 15:604-612.
40. Bonevski B, Sanson-Fisher R, Girgis A, Burton L, Cook P, Boyes A: Evaluation
of an instrument to assess the needs of patients with cancer. Cancer
2000, 88:217-225.
Turner et al. BMC Cancer 2011, 11:48
http://www.biomedcentral.com/1471-2407/11/48
Page 8 of 9
41. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M,
Yellen SB, Winicour P, Brannon J: Functional Assessment of Cancer
Therapy (FACT) scale: Development and validation of the general
measure. Journal of Clinical Oncology 1993, 11:570-579.
42. EuroQol Group: EuroQol-a new facility for the measurement of health-
related quality of life. The EuroQol Group. Health Policy 1990, 16:199-208.
43. Bosmans JE, Hermens ML, de Bruijne MC, van Hout HP, Terluin B,
Bouter LM, Stalman WA, van Tulder MW: Cost effectiveness of usual
general practitioner care with or without antidepressant medication for
patients with minor or mild-major depression. Journal of Affective
Disorders 2008, 111:106-12.
44. Kissane DW, Wein S, Love A, Lee XQ, Lee PL, Clarke DM: The
Demoralization Scale: a report of its development and preliminary
validation. Journal of Palliative Care 2004, 20:269-76.
45. Clarke DM, Kissane DW, Trauer T, Smith GC: Demoralization, anhedonia
and grief in patients with severe physical illness. World Psychiatry 2005,
4:96-105.
46. Turner J, Clavarino A, Yates P, Hargraves M, Connors V, Hausmann S:
Oncology nurses’ perception of their supportive care for parents with
advanced cancer: challenges and educational needs. Psycho-Oncology
2007, 16:149-157.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2407/11/48/prepub
doi:10.1186/1471-2407-11-48
Cite this article as: Turner et al.: A randomised trial of a psychosocial
intervention for cancer patients integrated into routine care: the
PROMPT study (promoting optimal outcomes in mood through tailored
psychosocial therapies). BMC Cancer 2011 11:48.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Turner et al. BMC Cancer 2011, 11:48
http://www.biomedcentral.com/1471-2407/11/48
Page 9 of 9
